Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: Systematic review and meta-analysis

Diabetologia

Volumn 51, Issue 6, 2008, Pages 941-951

  Jeitler, K ^a,b   Horvath, K ^a   Berghold, A ^a   Gratzer, T W ^a,b   Neeser, K ^c   Pieber, T R ^a,b   Siebenhofer, A ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b JOANNEUM RESEARCH   (Austria)

^c Institute for Medical Informatics and Biostatistics   (Switzerland)

Author keywords

Diabetes mellitus; Drug administration schedule; Glycosylated haemoglobin A; Hypoglycaemia; Insulin infusion systems; Insulin administration and dosage; Meta analysis; Randomised controlled trials; Review; Subcutaneous injections

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; INSULIN ZINC SUSPENSION;

ARTICLE; BIBLIOGRAPHIC DATABASE; CENTRAL; CLINICAL TRIAL; DIABETES MELLITUS; DRUG DOSE COMPARISON; EMBASE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MEDLINE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ADULT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 43049083274     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-0974-3     Document Type: Article

References (48)

1. Pickup JC, Keen H, Parsons JA, Alberti KG (1978) Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. BMJ 1:204-207
2. Chantelau E, Spraul M, Muhlhauser I, Gause R, Berger M (1989) Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience. Diabetologia 32:421-426
3. Guinn TS, Bailey GJ, Mecklenburg RS (1988) Factors related to discontinuation of continuous subcutaneous insulin-infusion therapy. Diabetes Care 11:46-51
4. Guilhem I, Leguerrier AM, Lecordier F, Poirier JY, Maugendre D (2006) Technical risks with subcutaneous insulin infusion. Diabetes Metab 32:279-284
5. Plotnick LP, Clark LM, Brancati FL, Erlinger T (2003) Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 26:1142-1146
6. Richardson T, Kerr D (2003) Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol 4:661-667
7. Pickup J, Mattock M, Kerry S (2002) Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 324:705
8. Retnakaran R, Hochman J, DeVries JH et al (2004) Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care 27:2590-2596
9. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 354:1896-1900
10. Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions 4.2.4 [updated March 2005]. In: The Cochrane Library (Issue 2) 2005. Wiley, Chichester
11. Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12
12. Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408-412
13. Bak JF, Nielsen OH, Pedersen O, Beck-Nielsen H (1987) Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patients. Diabetes Res 6:155-158
14. Bangstad HJ, Kofoed-Enevoldsen A, Dahl-Jorgensen K, Hanssen KF (1992) Glomerular charge selectivity and the influence of improved blood glucose control in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 35:1165-1169
15. Bangstad HJ, Osterby R, Dahl-Jorgensen K, Berg KJ, Hartmann A, Hanssen KF (1994) Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 37:483-490
16. Berg TJ, Nourooz-Zadeh J, Wolff SP, Tritschler HJ, Bangstad HJ, Hanssen KF (1998) Hydroperoxides in plasma are reduced by intensified insulin treatment. A randomized controlled study of IDDM patients with microalbuminuria. Diabetes Care 21:1295-1300
17. Brinchmann-Hansen O, Dahl-Jorgensen K, Hanssen KF, Sandvik L (1985) Effects of intensified insulin treatment on various lesions of diabetic retinopathy. Am J Ophthalmol 100:644-653
18. Brinchmann-Hansen O, Dahl-Jorgensen K, Hanssen KF, Sandvik L (1988) Oscillatory potentials, macular recovery time, and diabetic retinopathy through 3 years of intensified insulin treatment. Ophthalmology 95:1358-1366
19. Chiasson JL, Ducros F, Poliquin-Hamet M, Lopez D, Lecavalier L, Hamet P (1984) Continuous subcutaneous insulin infusion (Mill-Hill Infuser) versus multiple injections (Medi-Jector) in the treatment of insulin-dependent diabetes mellitus and the effect of metabolic control on microangiopathy. Diabetes Care 7:331-337
20. Ciavarella A, Vannini P, Flammini M, Bacci L, Forlani G, Borgnino LC (1985) Effect of long-term near-normoglycemia on the progression of diabetic nephropathy. Diabetes Metab 11:3-8
21. DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ, Dutch Insulin Pump Study Group (2002) A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 25:2074-2080
22. Hanaire-Broutin H, Melki V, Bessieres-Lacombe S, Tauber JP (2000) Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes. Diabetes Care 23:1232-1235
23. Hanssen KF, Dahl-Jorgensen K, Brinchmann-Hansen O (1985) The influence of strict control on diabetic complications. Acta Endocrinol 272:57-60
24. Hirsch IB, Bode BW, Garg S et al (2005) Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 28:533-538
25. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes O (1985) Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. BMJ 290:811-815
26. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF et al (1986) Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. BMJ 293:1195-1199
27. Dahl-Jorgensen K, Torjesen P, Hanssen KF, Sandvik L, Aagenaes O (1987) Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment. Diabetes 36:1-5
28. Dahl-Jorgensen K (1987) Near-normoglycemia and late diabetic complications. The Oslo Study. Acta Endocrinol 284:1-38
29. Dahl-Jorgensen K, Hanssen KF, Kierulf P, Bjoro T, Sandvik L, Aagenaes O (1988) Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study. Acta Endocrinol 117:19-25
30. Home PD, Capaldo B, Burrin JM, Worth R, Alberti KG (1982) A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII. Diabetes Care 5:466-471
31. Husted SE, Nielsen HK, Bak JF, Beck-Nielsen H (1989) Antithrombin III activity, von Willebrand factor antigen and platelet function in young diabetic patients treated with multiple insulin injections versus insulin pump treatment. Eur J Clin Invest 19:90-94
32. Nosadini R, Velussi M, Fioretto P et al (1988) Frequency of hypoglycaemic and hyperglycaemic-ketotic episodes during conventional and subcutaneous continuous insulin infusion therapy in IDDM. Diabetes Nutr Metab 1:289-296
33. Saurbrey N, Arnold-Larsen S, Moller-Jensen B, Kuhl C (1988) Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen. Diabet Med 5:150-153
34. Schiffrin A, Belmonte MM (1982) Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin. A one-year prospective study. Diabetes 31:255-264
35. Schmitz A, Christiansen JS, Christensen CK, Hermansen K, Mogensen CE (1989) Effect of pump versus pen treatment on glycaemic control and kidney function in long-term uncomplicated insulin-dependent diabetes mellitus (IDDM). Dan Med Bull 36:176-178
36. Schottenfeld-Naor Y, Galatzer A, Karp M, Josefsberg Z, Laron Z (1985) Comparison of metabolic and psychological parameters during continuous subcutaneous insulin infusion and intensified conventional insulin treatment in type I diabetic patients. Isr J Med Sci 21:822-828
37. Tsui E, Barnie A, Ross S, Parkes R, Zinman B (2001) Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Diabetes Care 24:1722-1727
38. Ziegler D, Dannehl K, Koschinsky T, Toeller M, Gries FA (1990) Comparison of continuous subcutaneous insulin infusion and intensified conventional therapy in the treatment of type I diabetes: a two-year randomized study. Diabetes Nutr Metab 3:203-213
39. Hoogma RP, Hammond PJ, Gomis R et al (2006) Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diab Med 23:141-147
40. Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV (2004) A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 27:1554-1558
41. Schiffrin A, Desrosiers M, Moffatt M, Belmonte MM (1983) Feasibility of strict diabetes control in insulin-dependent diabetic adolescents. J Pediatr 103:522-527
42. Schiffrin AD, Desrosiers M, Aleyassine H, Belmonte MM (1984) Intensified insulin therapy in the type I diabetic adolescent: a controlled trial. Diabetes Care 7:107-113
43. Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gitelman SE (2005) A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 28:15-19
44. Herman WH, Ilag LL, Johnson SL et al (2005) A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 28:1568-1573
45. Raskin P, Bode BW, Marks JB et al (2003) Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care 26:2598-2603
46. Siebenhofer A, Plank J, Berghold A et al (2006) Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev, Issue 2, Art. no.: CD003287. DOI 10.1002/14651858.CD003287.pub4
47. Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N (2004) Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess 8:1-171
48. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R (2003) Insulin pump therapy: a meta-analysis. Diabetes Care 26:1079-1087